Operational and Trading Update

AI SummaryClose X

Vulcan Two Group plc reported significant progress in the six months ended 30 June 2026, following the acquisitions of CloudRx, Hyperdrug, and Webmed. Key operational developments include the ongoing fit-out of a new 22,000 sq ft distribution facility in Leeds, the integration of an enterprise resource planning system, and the transfer of Webmed's fulfilment to CloudRx. The company is also developing a new web platform, expected to launch before the end of Q3, and has strengthened its executive team with key hires including a new Chief Financial Officer and Chief Pharmacy Officer. Trading has seen strong sales growth in the general healthcare sector, particularly in women's health and ADHD medications. While rationalising some lower-margin customers is expected to reduce near-term revenues, it is projected to improve gross margin percentage, with 85% of revenues now derived from customers paying at point of order. The company maintained strong cash balances of approximately £6.0 million at period end.

Disclaimer*

UK 100

Latest directors dealings